290 related articles for article (PubMed ID: 17636707)
1. Embryo freezing for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Amso N
Cochrane Database Syst Rev; 2007 Jul; (3):CD002806. PubMed ID: 17636707
[TBL] [Abstract][Full Text] [Related]
2. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
D'Angelo A; Amso N
Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
[TBL] [Abstract][Full Text] [Related]
3. "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Amso N
Cochrane Database Syst Rev; 2002; (3):CD002811. PubMed ID: 12137659
[TBL] [Abstract][Full Text] [Related]
4. Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review.
D'Angelo A; Amso NN
Hum Reprod; 2002 Nov; 17(11):2787-94. PubMed ID: 12407029
[TBL] [Abstract][Full Text] [Related]
5. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Amso NN; Hassan R
Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
[TBL] [Abstract][Full Text] [Related]
6. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Brown J; Amso NN
Cochrane Database Syst Rev; 2011 Jun; (6):CD002811. PubMed ID: 21678336
[TBL] [Abstract][Full Text] [Related]
7. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Brown J; Amso NN
Cochrane Database Syst Rev; 2011 Feb; (2):CD002811. PubMed ID: 21328256
[TBL] [Abstract][Full Text] [Related]
8. Fresh versus frozen embryo transfers in assisted reproduction.
Wong KM; van Wely M; Mol F; Repping S; Mastenbroek S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011184. PubMed ID: 28349510
[TBL] [Abstract][Full Text] [Related]
9. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
Youssef MA; Al-Inany HG; Evers JL; Aboulghar M
Cochrane Database Syst Rev; 2011 Feb; (2):CD001302. PubMed ID: 21328249
[TBL] [Abstract][Full Text] [Related]
10. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad S; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
[TBL] [Abstract][Full Text] [Related]
11. Fresh versus frozen embryo transfers in assisted reproduction.
Zaat T; Zagers M; Mol F; Goddijn M; van Wely M; Mastenbroek S
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011184. PubMed ID: 33539543
[TBL] [Abstract][Full Text] [Related]
12. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
Aboulghar M; Evers JH; Al-Inany H
Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404
[TBL] [Abstract][Full Text] [Related]
13. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
Youssef MA; Abou-Setta AM; Lam WS
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
[TBL] [Abstract][Full Text] [Related]
14. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
Youssef MA; Mourad S
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
[TBL] [Abstract][Full Text] [Related]
15. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; McNeil A; van Rumste MM
Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
19. Cabergoline for preventing ovarian hyperstimulation syndrome.
Tang H; Hunter T; Hu Y; Zhai SD; Sheng X; Hart RJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD008605. PubMed ID: 22336848
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad SM; Wang A; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008605. PubMed ID: 33851429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]